Rocket Pharmaceuticals (RCKT) Common Equity (2014 - 2026)
Rocket Pharmaceuticals (RCKT) posted Common Equity of $368.83 million for Q2 2026, up 4.1% from $354.21 million a year earlier and up 54.9% from the prior quarter.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) Common Equity (2014 - 2026) Analysis & Trends
At the end of FY2025, Rocket Pharmaceuticals' Common Equity came in at $277.22 million, down 40.2% from FY2024.
- Annual Common Equity shows a five-year compound annual growth rate of -11.3% (FY2020 to FY2025).
- In prior years, Rocket Pharmaceuticals' Common Equity was $463.23 million in FY2024 (-6.0%), $492.57 million in FY2023 (+0.6%), $489.69 million in FY2022 (+7.7%) and $454.72 million in FY2021 (-9.7%).
- The Q2 2026 figure stands as the highest quarterly Common Equity since Q1 2025.
- On a year-over-year basis, Common Equity increased in 1 of the last eight quarters, with an average decline of 17.8%.
- The strongest year-over-year quarter for Common Equity in the past five years was Q3 2021, with growth of 100.8%; the weakest was Q1 2026, with a decline of 42.2%.
- According to Business Quant data, Common Equity for the three prior quarters was $238.04 million (Q1 2026), $277.22 million (Q4 2025) and $313.67 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Rocket Pharmaceuticals | 283.71 Mn | 283.71 Mn | - | 368.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 368.83 Mn |
| Mar 31, 2026 | 238.04 Mn |
| Dec 31, 2025 | 277.22 Mn |
| Sep 30, 2025 | 313.67 Mn |
| Jun 30, 2025 | 354.21 Mn |
| Mar 31, 2025 | 412.14 Mn |
| Dec 31, 2024 | 463.23 Mn |
| Sep 30, 2024 | 329.77 Mn |
| Jun 30, 2024 | 384.64 Mn |
| Mar 31, 2024 | 441.50 Mn |
| Dec 31, 2023 | 492.57 Mn |
| Sep 30, 2023 | 541.09 Mn |
| Jun 30, 2023 | 402.97 Mn |
| Mar 31, 2023 | 458.88 Mn |
| Dec 31, 2022 | 489.69 Mn |
| Sep 30, 2022 | 367.31 Mn |
| Jun 30, 2022 | 387.70 Mn |
| Mar 31, 2022 | 417.62 Mn |
| Dec 31, 2021 | 454.72 Mn |
| Sep 30, 2021 | 485.66 Mn |
API Access
Rocket Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RCKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RCKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RCKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();